BIOT
•
Equity
L&G PHARMA BREAKTHROUGH UCITS ETF
TER (bps):
49
AUM (USD m):
19
ISIN:
IE00BF0H7608
Domicile:
Ireland
Share Class Currency:
USD
ESG:
No
Geographical Focus:
Global
As of:
09 May 2024
Climate Fund:
No
Benchmark
The Solactive Pharma Breakthrough Value Index aims to track the performance of a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. it uses a two-fold approach that is primarily based on the trend in the valuation of a company’s orphan drug portfolio and its overall revenue forecasts. The Index selects stocks that meet certain size and liquidity requirements.
RELATED ARTICLES
MOST READ
1
People Moves
Blackrock’s iShares head Ramji to depart
2
Industry Updates
Amundi launches Europe’s first fixed maturity German bund ETF
3
Analysis
BlackRock world ETF flash crash on Deutsche Boerse: A deep dive
4
Analysis
Postcard from Paris: ETFs sense ‘game changing’ moment in France
5
Industry Updates